Skip to content
Screener

Wave Life Sciences WVE Q2 2026 earnings

Reported July 30, 2026 · Before market open

Revenue$2.3MMiss by $5.2M
EPS-$0.34Miss by $0.04
Revenue estimate$7.4M
EPS estimate-$0.30

Next report

Nov 9, 2026 (in 2 months)
Revenue estimate$5.0M
EPS estimate-$0.33

Financials

Q2 2026

Income statement

See full
Revenue$2.3M-73.9%
Operating income-$73.8M-39.9%
Net income-$69.4M-37.4%
EPS (diluted)-$0.34-9.7%

Balance sheet

See full
Cash & equivalents$368.0M+76.5%
Total debt$43.6M+101%
Total equity$453.5M+226%
Total assets$558.3M+121%

Cash flow

See full
Operating cash flow-$53.6M-16.5%
CapEx$884.0K+189%
Free cash flow-$54.5M-17.6%

Valuation & ratios

Valuation

as of 09/17/26
See full
Market cap$878.83M-18.0%
Enterprise value$554.42M-37.1%
P/S15.1×—

Returns & leverage

See full
Return on equity-68.3%—
Debt / equity0.1×-0.1×
Current ratio10×+7.4×

FAQ

When did Wave Life Sciences report Q2 2026 earnings?
Wave Life Sciences (WVE) reported Q2 2026 earnings on July 30, 2026 before market open.
What were Wave Life Sciences's Q2 2026 revenue and EPS?
Wave Life Sciences reported revenue of $2.3M and eps of $-0.34 for Q2 2026.
Did Wave Life Sciences beat estimates in Q2 2026?
Revenue missed the consensus estimate of $7.4M by $5.2M. EPS missed the consensus estimate of $-0.30 by $0.04.
How did Wave Life Sciences's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 73.9% from $8.7M a year earlier and eps declined 9.7% from $-0.31.
Where can I find Wave Life Sciences's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-324917) and the 10-Q periodic report (0001193125-26-324949) directly on SEC EDGAR. The filing index links above go to sec.gov.